Julio Cortijo Selected Research

Bronchial Spasm

8/2012	Pharmacological characterization of abediterol, a novel inhaled β(2)-adrenoceptor agonist with long duration of action and a favorable safety profile in preclinical models.
1/2005	Effects of bemiparin on airway responses to antigen in sensitized Brown-Norway rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julio Cortijo Research Topics

Disease

19	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 06/2005
14	Fibrosis (Cirrhosis) 04/2024 - 01/2015
12	Inflammation (Inflammations) 07/2023 - 04/2002
11	Asthma (Bronchial Asthma) 07/2023 - 01/2003
9	Pulmonary Fibrosis (Fibrosing Alveolitis) 04/2024 - 10/2013
8	Respiratory Tract Diseases (Respiratory Tract Disease) 10/2022 - 01/2012
6	Idiopathic Pulmonary Fibrosis 01/2021 - 02/2012
5	Pulmonary Hypertension 04/2024 - 10/2013
5	Neoplasms (Cancer) 07/2023 - 01/2012
4	Lung Diseases (Lung Disease) 03/2021 - 01/2005
4	Rhinosinusitis 01/2019 - 02/2015
3	Pneumonia (Pneumonitis) 01/2022 - 02/2015
3	Hypoxia (Hypoxemia) 01/2018 - 01/2012
3	Necrosis 08/2016 - 06/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 08/2016 - 07/2009
3	Virus Diseases (Viral Diseases) 01/2016 - 09/2011
3	Respiratory Syncytial Virus Infections 01/2016 - 01/2012
3	Infections 01/2013 - 11/2005
3	Ciliary Motility Disorders (Primary Ciliary Dyskinesia) 07/2012 - 05/2010
2	Sunburn 07/2023 - 01/2023
2	Hypersensitivity (Allergy) 02/2023 - 09/2022
2	Carcinogenesis 01/2023 - 01/2012
2	Erythema 01/2023 - 02/2022
2	Hypertension (High Blood Pressure) 11/2022 - 01/2018
2	Lung Neoplasms (Lung Cancer) 03/2021 - 01/2021
2	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 10/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2019
2	Nasal Polyps (Nasal Polyp) 03/2017 - 02/2015
2	Nausea 01/2017 - 06/2005
2	Heart Failure 08/2016 - 06/2008
2	Myocardial Infarction 08/2016 - 12/2004
2	Bronchial Spasm 08/2012 - 01/2005
2	Atherosclerosis 11/2007 - 05/2006
2	Respiratory Hypersensitivity 03/2006 - 01/2005
1	Cardiomegaly (Heart Hypertrophy) 11/2023
1	Pulmonary Arterial Hypertension 11/2023
1	Polyps 02/2023
1	Eosinophilia 02/2023
1	COVID-19 11/2022
1	Critical Illness (Critically Ill) 11/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2021
1	Disease Progression 06/2021
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 06/2021
1	Vascular Remodeling 05/2021
1	Pathologic Processes 03/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2021

Drug/Important Bio-Agent (IBA)

11	Bleomycin (Blenoxane)FDA LinkGeneric 04/2024 - 10/2013
11	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2023 - 01/2005
9	MucinsIBA 01/2021 - 01/2005
7	Interleukin-8 (Interleukin 8)IBA 02/2023 - 12/2004
7	Phosphodiesterase 4 InhibitorsIBA 01/2017 - 06/2005
6	Proteins (Proteins, Gene)FDA Link 02/2022 - 01/2005
6	SmokeIBA 12/2021 - 06/2010
6	RoflumilastIBA 01/2017 - 06/2005
5	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2023 - 05/2012
5	LipopolysaccharidesIBA 01/2022 - 06/2008
5	Biomarkers (Surrogate Marker)IBA 06/2021 - 08/2014
5	AntioxidantsIBA 01/2013 - 09/2011
4	Mucin-1 (CA 15-3 Antigen)IBA 03/2021 - 02/2015
4	Muscarinic AntagonistsIBA 01/2019 - 11/2009
3	Interleukin-11 (Interleukin 11)IBA 04/2024 - 11/2022
3	Small Interfering RNA (siRNA)IBA 11/2023 - 07/2010
3	Paclitaxel (Taxol)FDA LinkGeneric 07/2023 - 01/2022
3	Acetylcysteine (Siran)FDA LinkGeneric 11/2022 - 01/2012
3	Protein Isoforms (Isoforms)IBA 05/2021 - 01/2017
3	CytokinesIBA 01/2021 - 02/2015
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 12/2009
3	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2019 - 08/2014
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 02/2015
3	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2017 - 04/2002
3	Messenger RNA (mRNA)IBA 08/2016 - 01/2013
3	roflumilast N-oxideIBA 08/2014 - 01/2013
3	Angiotensin IIIBA 09/2010 - 05/2006
3	Serotonin (5 Hydroxytryptamine)IBA 06/2010 - 01/2005
2	MonocrotalineIBA 04/2024 - 11/2023
2	Antineoplastic Agents (Antineoplastics)IBA 02/2023 - 09/2022
2	Peptides (Polypeptides)IBA 10/2022 - 01/2021
2	Fluticasone (Cutivate)FDA LinkGeneric 01/2022 - 01/2019
2	Janus Kinase InhibitorsIBA 01/2022 - 06/2021
2	Interleukin-6 (Interleukin 6)IBA 06/2021 - 01/2013
2	LAS190792IBA 01/2019 - 10/2017
2	Vasodilator Agents (Vasodilators)IBA 01/2018 - 01/2016
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2017 - 01/2013
2	aclidinium bromideIBA 11/2016 - 11/2009
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 08/2016 - 01/2012
2	RNA (Ribonucleic Acid)IBA 01/2015 - 01/2013
2	LipidsIBA 01/2014 - 07/2006
2	Nitric Oxide Synthase (NO Synthase)IBA 10/2013 - 06/2010
2	Adenylate KinaseIBA 07/2012 - 05/2010
1	Melanins (Melanin)IBA 07/2023
1	obacunoneIBA 07/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2023
1	Galectin 3 (LGALS3)IBA 12/2022
1	InflammasomesIBA 11/2022
1	Janus KinasesIBA 01/2022
1	Superoxides (Superoxide)IBA 01/2022
1	Monoclonal AntibodiesIBA 06/2021

Therapy/Procedure

7	Therapeutics 01/2021 - 01/2012
2	Parenteral Nutrition 01/2014 - 07/2006
1	Biological Therapy 07/2023